American Diabetes Association
Browse
DOCUMENT
Supplementary_Table_S1.pdf (58.81 kB)
DOCUMENT
Supplementary_Table_S2_PP_analysis_outcomes.pdf (321.15 kB)
DOCUMENT
Supplementary_Table_S3.pdf (149.5 kB)
1/0
3 files

Efficacy and feasibility of Intradialytic Plantar Electrical Stimulation in patients with diabetes: A Randomized Double-Blind Controlled Trial

figure
posted on 2024-09-24, 15:24 authored by Myeounggon Lee, Abdullah Hamad, Mehrnaz Azarian, Jaewon Beom, Abderrahman Ouattas, Mohammad Dehghan Rouzi, Naima Rodriguez, Nhi Quach, Rania Ibrahim, Mincy Mathew, Talal Talal, Fadwa Al‑Ali, Bijan Najafi

OBJECTIVE

This study investigates the efficacy and feasibility of electrical stimulation (E-Stim) on sensory fibers of the plantar region during hemodialysis (HD) sessions, aiming to improve mobility in diabetes patients by providing a connection between electrical stimulation and enhanced mobility with minimal patient effort required.

RESEARCH DESIGN AND METHODS

Participants 18 and above, undergoing HD in the diabetes patients, and able to walk at least 10 meters with or without aid, were recruited and divided into an intervention group (IG) receiving 1-hour intradialytic E-Stim 3 times/week, and a control group (CG) using an identical non-functional device, for 12-week. Gait, physical activity, patient-reported outcomes, and the technology acceptance model were assessed to evaluate the intervention's effectiveness and acceptance.

RESULTS

Out of 117 initial participants, 97 completed the study. Significant improvements were observed in the IG compared to the CG in gait performance (stride time at dual-task and fast walking), physical activity (stand-to-walk and sit-to-stand), quality of life, plantar numbness, and cognitive function after 12-week. The IG showed magnitude of improvements on gait performance and physical activity metrics are associated with enhancements on quality of life and cognitive function, respectively. The IG also reported higher 'usefulness' and 'usage satisfaction', with a greater willingness to continue using E-Stim at home.

CONCLUSIONS

The 12-week intradialytic E-Stim intervention is a feasible and effective method to enhance gait performance, physical activity level, cognitive function and other patient-reported outcomes in HD patients, representing a practical, low-risk therapy option for those unable to engage in traditional exercise programs.

Funding

This project has been supported by a grant from the Qatar National Research Foundation (NPRP 10-0208-170400, http://www.qnrf.org/) and in-kind support from Hamad Medical Corporation (Doha, Qatar). The content is solely the responsibility of the authors and does not necessarily represent the official views of the QNRF or HMC.

History

Usage metrics

    Diabetes Care

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC